Summary
EpiBarrier is focused on the study of epilepsy, a chronic neurological disease, that affects approximately 65 million people worldwide. Major challenges in epilepsy include social disadvantages, an increased risk for early mortality, and accompanying co-morbidities such as...
More information & hyperlinks